Abstract
Mesenchymal stem cells have been increasingly introduced to have great potential in regenerative medicine, immunotherapy, and gene therapy due to their unique properties of self-renewal and differentiation into multiple cell lineages. Studies have shown that these properties may be limited and changed by senescence-associated growth arrest under different culture conditions. This study aimed to present the ability of some growth factors on human umbilical cord mesenchymal (hUCM) cells expansion and telomerase activity. To optimize hUCM cell growth, epidermal growth factor (EGF) and fibroblast growth factor (FGF) were utilized in culture media, and the ability of these growth factors on the expression of the telomerase reverse transcriptase (TERT) gene and cell cycle phases was investigated. TERT mRNA expression increased in the hUCM cells treated by EGF and FGF. So, the untreated hUCM cells expressed 30.49 ± 7.15% of TERT, while EGF-treated cells expressed 51.82 ± 12.96% and FGF-treated cells expressed 33.77 ± 11.55% of TERT. Exposure of hUCM cells to EGF or FGF also promoted the progression of cells from G1 to S phase of the cell cycle and induced them to decrease the number of cells entering the G2/M phase. Our study showed that EGF and, to a lesser extent, FGF amplify the proliferation and expansion of hUCM cells.
Similar content being viewed by others
References
Alenzi F. Q.; Alenazi B. Q.; Ahmad S. Y.; Salem M. L.; Al-Jabri A. A.; Wyse R. K. The haemopoietic stem cell: between apoptosis and self renewal. Yale J. Biol. Med. 82: 7–18; 2009.
Bayne S.; Liu J. P. Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol. Cell. Endocrinol. 240: 11–22; 2005.
Budiyanto A.; Bito T.; Kunisada M.; Ashida M.; Ichihashi M.; Ueda M. Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells. J. Invest. Dermatol. 121: 1088–1094; 2003.
Cao F. J.; Feng S. Q. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin. Med. J. (Engl) 122: 225–231; 2009.
Chomal M. R. Analysis of telomerase activity and telomere lengths in human umbilical cord cell populations during ex vivo amplification of hematopoietic stem cells. Worcester Polytechnic Institute, Worcester; 2003.
Dhulipala V. C.; Welshons W. V.; Reddy C. S. Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review. Hum. Exp. Toxicol. 25: 675–682; 2006.
Duong J.; Mii S.; Uchugonova A.; Liu F.; Moossa A. R.; Hoffman R. M. Real-time confocal imaging of trafficking of nestin-expressing multipotent stem cells in mouse whiskers in long-term 3-D histoculture. In Vitro Cell. Dev. Biol. Anim. 48: 301–305; 2012.
Garcia C. M.; Yu K.; Zhao H.; Ashery-Padan R.; Ornitz D. M.; Robinson M. L.; Beebe D. C. Signaling through FGF receptor-2 is required for lens cell survival and for withdrawal from the cell cycle during lens fiber cell differentiation. Dev. Dyn. 233: 516–527; 2005.
Gauthaman K.; Fong C. Y.; Subramanian A.; Biswas A.; Bongso A. ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton’s jelly stem cells after cryopreservation. Stem Cell Rev. 6: 665–676; 2010.
Hoffman R. M. To do tissue culture in two or three dimensions? That is the question. Stem Cell 11: 105–111; 1993.
Hoffman R. M. Histocultures and their use. Encyclopedia of life sciences. Wiley, Chichester; 2010.
Hulleman E.; Boonstra J. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell. Mol. Life Sci. 58: 80–93; 2001.
Jeon B. G.; Kumar B. M.; Kang E. J.; Ock S. A.; Lee S. L.; Kwack D. O.; Byun J. H.; Park B. W.; Rho G. J. Characterization and comparison of telomere length, telomerase and reverse transcriptase activity and gene expression in human mesenchymal stem cells and cancer cells of various origins. Cell Tissue Res. 345: 149–161; 2011.
LeVea C. M.; Reeder J. E.; Mooney R. A. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation. Exp. Cell Res. 297: 272–284; 2004.
Liang C. M.; Tai M. C.; Chang Y. H.; Chen Y. H.; Chen C. L.; Chien M. W.; Chen J. T. Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cells. Mol. Vis. 16: 2559–2571; 2010.
Liang X. J.; Chen X. J.; Yang D. H.; Huang S. M.; Sun G. D.; Chen Y. P. Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro. Cell Biol. Int. 36: 215–221; 2012.
Liu F.; Uchugonova A.; Kimura H.; Zhang C.; Zhao M.; Zhang L.; Koenig K.; Duong J.; Aki R.; Saito N.; Mii S.; Amoh Y.; Katsuoka K.; Hoffman R. M. The bulge area is the major hair follicle source of nestin-expressing pluripotent stem cells which can repair the spinal cord compared to the dermal papilla. Cell Cycle 10: 830–839; 2011.
Liu S. J.; Cai Z. W.; Liu Y. J.; Dong M. Y.; Sun L. Q.; Hu G. F.; Wei Y. Y.; Lao W. D. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J. Gastroenterol. 10: 1246–1249; 2004.
Maida Y.; Kyo S.; Kanaya T.; Wang Z.; Yatabe N.; Tanaka M.; Nakamura M.; Ohmichi M.; Gotoh N.; Murakami S.; Inoue M. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21: 4071–4079; 2002.
Majore I.; Moretti P.; Stahl F.; Hass R.; Kasper C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev. 7: 17–31; 2011.
Masutomi K.; Yu E. Y.; Khurts S.; Ben-Porath I.; Currier J. L.; Metz G. B.; Brooks M. W.; Kaneko S.; Murakami S.; DeCaprio J. A.; Weinberg R. A.; Stewart S. A.; Hahn W. C. Telomerase maintains telomere structure in normal human cells. Cell 114: 241–253; 2003.
Miura T.; Katakura Y.; Yamamoto K.; Uehara N.; Tsuchiya T.; Kim E. H.; Shirahata S. Neural stem cells lose telomerase activity upon differentiating into astrocytes. Cytotechnology 36: 137–144; 2001.
Murthy V. Telomerase activity in human umbilical cord cell populations containing hematopoietic stem cells. Worcester Polytechnic Institute, Worcester; 2002.
Salehinejad P.; Alitheen N. B.; Ali A. M.; Omar A. R.; Mohit M.; Janzamin E.; Samani F. S.; Torshizi Z.; Nematollahi-Mahani S. N. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell. Dev. Biol. Anim. 48: 75–83; 2012a.
Salehinejad P.; Alitheen N. B.; Nematollahi-Mahani S. N.; Ali A. M.; Omar A. R.; Janzamin E.; Hajghani M. Effect of culture media on expansion properties of human umbilical cord matrix-derived mesenchymal cells. Cytotherapy 14: 948–953; 2012b.
Schwob A. E.; Nguyen L. J.; Meiri K. F. Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells. Mol. Biol. Cell 19: 1548–1560; 2008.
Serakinci N.; Graakjaer J.; Kolvraa S. Telomere stability and telomerase in mesenchymal stem cells. Biochimie 90: 33–40; 2008.
Seshareddy B. K. Human Wharton’s jelly cells—isolation and characterization in different growth conditions. Kansas State University, Kansas; 2008.
Stenderup K.; Justesen J.; Clausen C.; Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919–926; 2003.
Tamura M.; Kawabata A.; Ohta N.; Uppalapati L.; Becker K. G.; Troyer D. Wharton’s jelly stem cell as agent for cancer therapy. Open Tissue Eng. Regen. Med. J. 4: 39–47; 2011.
Upadhyay D.; Chang W.; Wei K.; Gao M.; Rosen G. D. Fibroblast growth factor-10 prevents H2O2-induced cell cycle arrest by regulation of G1 cyclins and cyclin dependent kinases. FEBS Lett. 581: 248–252; 2007.
Wang F. Z.; Sha L.; Zhang W. Y.; Wu L. Y.; Qiao L.; Li N.; Zhang X. D.; Ye L. H. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol. Sin. 28: 431–438; 2007.
Wojtyla A.; Gladych M.; Rubis B. Human telomerase activity regulation. Mol. Biol. Rep. 38: 3339–3349; 2011.
Young H. E.; Black A. C. Adult stem cells. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 276: 75–102; 2004.
Zeng H. L.; Zhong Q.; Qin Y. L.; Bu Q. Q.; Han X. A.; Jia H. T.; Liu H. W. Hypoxia-mimetic agents inhibit proliferation and alter the morphology of human umbilical cord-derived mesenchymal stem cells. BMC Cell Biol. 12: 32; 2011.
Zhu X.; Kumar R.; Mandal M.; Sharma N.; Sharma H. W.; Dhingra U.; Sokoloski J. A.; Hsiao R.; Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. U.S.A. 93: 6091–6095; 1996.
Zimmermann S.; Voss M.; Kaiser S.; Kapp U.; Waller C. F.; Martens U. M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17: 1146–1149; 2003.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Salehinejad, P., Alitheen, N.B., Mandegary, A. et al. Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells. In Vitro Cell.Dev.Biol.-Animal 49, 515–523 (2013). https://doi.org/10.1007/s11626-013-9631-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-013-9631-3